Intact Investment Management Inc. Has $632,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Intact Investment Management Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 36.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,200 shares of the healthcare conglomerate’s stock after selling 700 shares during the period. Intact Investment Management Inc.’s holdings in UnitedHealth Group were worth $632,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after acquiring an additional 527,526 shares during the period. Northern Trust Corp increased its holdings in shares of UnitedHealth Group by 3.6% in the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after purchasing an additional 341,749 shares during the period. Bank of New York Mellon Corp boosted its stake in UnitedHealth Group by 2.2% during the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock valued at $4,155,676,000 after buying an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after purchasing an additional 27,127 shares in the last quarter. Finally, Sanders Capital LLC boosted its holdings in shares of UnitedHealth Group by 6.5% during the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after purchasing an additional 352,710 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a report on Thursday, April 4th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Trading Up 0.3 %

UNH stock opened at $495.35 on Monday. The firm has a market cap of $455.76 billion, a P/E ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The company’s 50-day simple moving average is $485.84 and its 200-day simple moving average is $514.07. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 earnings per share. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.